[
    [
        {
            "time": "",
            "original_text": "“最受关注A股上市公司”评选结果出炉：10家胜出，四大市场“一哥”入选",
            "features": {
                "keywords": [
                    "A股",
                    "上市公司",
                    "评选",
                    "一哥"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "投资"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "“最受关注A股上市公司”评选结果出炉：10家胜出，四大市场“一哥”入选",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "乳腺癌成为全球第一大癌！罗氏等跨国药企仍是主要玩家，复宏汉霖新药三季度仅卖22支",
            "features": {
                "keywords": [
                    "乳腺癌",
                    "罗氏",
                    "复宏汉霖",
                    "新药",
                    "三季度"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "乳腺癌成为全球第一大癌！罗氏等跨国药企仍是主要玩家，复宏汉霖新药三季度仅卖22支",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药行业重大事项点评：第四批带量采购拟中标结果产生 降价幅度符合预期",
            "features": {
                "keywords": [
                    "医药",
                    "带量采购",
                    "中标",
                    "降价"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药行业重大事项点评：第四批带量采购拟中标结果产生 降价幅度符合预期",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]